CTOs on the Move

PMV Pharmaceutcals

www.pmvpharma.com

 
PMV is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Shibu Sleeba
 Vice President, Information Technology Profile

Funding

PMV Pharmaceutcals raised $104M on 02/23/2017
PMV Pharmaceutcals raised $74M on 02/23/2017
PMV Pharmaceutcals raised $62M on 11/13/2019
PMV Pharmaceutcals raised $70M on 08/03/2020

Similar Companies

StimLabs

Stern at Home Therapy

Stern At Home Therapy is transforming how outpatient therapy is experienced.

Pfeiffer Pharmaceuticals

Pfeiffer Pharmaceuticals is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blue Earth Diagnostics

Blue Earth Diagnostics (BED) is a privately held diagnostics company focused on the development and commercialisation of molecular imaging technologies.

OrphoMed Inc

OrphoMed is a San Francisco based clinical stage pharmaceutical company focused on the development of novel first-in-class dimer conjugates with superior therapeutic profiles. The company is leveraging its proprietary dimer platform technology to address the issues of visceral hypersensitivity and hypermotility in functional gastrointestinal disorders. OrphoMed dimers are protected by composition of matter and method of use patents.